CR

Chitta Ranjan Sahoo

Active Director Director DIN 10683580
DIN 10683580 First appointment Jun 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Chitta Ranjan Sahoo

Data last updated:

Chitta Ranjan Sahoo is a Director at Trivital Pharma Private Limited (since 2024).

DIN 10683580
Primary Designation Director
First Appointment 26 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trivital Pharma Private Limited U46497OD2024PTC046194
Director26 Jun 20242024Active

Board colleagues of Chitta Ranjan Sahoo

NameDINCompanyDesignation
Biranchi Pratap Sahoo10683579Trivital Pharma Private LimitedManaging Director
Diptimayee Maharana10875883Trivital Pharma Private LimitedIndividual Subscriber

Directorship timeline

Open interactive timeline →
Trivital Pharma Private Limited
Premium access

Shareholding and investment profile for Chitta Ranjan Sahoo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chitta Ranjan Sahoo

Chitta Ranjan Sahoo currently holds 1 directorship: Trivital Pharma Private Limited (Director, since 26 Jun 2024).

Chitta Ranjan Sahoo was first appointed on 26 Jun 2024 as Director at Trivital Pharma Private Limited.

The current boards of Chitta Ranjan Sahoo's companies include Biranchi Pratap Sahoo (Trivital Pharma Private Limited), Diptimayee Maharana (Trivital Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available